Evidence map›Paper›PMID 22069547›Full record

ArticleToxins2010

the versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk.

Steffen Backert, Nicole Tegtmeyer

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Immunokinetic signatures ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Pathogens (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Association between the presence and genotype ofExperimental and therapeutic medicine · 2023
    Article
  8. Article
  9. Clinical Pathogenesis, Molecular Mechanisms of Gastric Cancer Development.Current topics in microbiology and immunology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. World journal of gastroenterology · 2017
    Article
  16. Occurrence ofGastroenterology and hepatology from bed to bench · 2017
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Steffen BackertArdmore House, School of Biomolecular and Biomedical Sciences, Belfield Campus, University College Dublin, Dublin-4, Ireland. Steffen.Backert@ucd.ie
Nicole Tegtmeyer
University College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By modulating important properties of eukaryotic cells, many bacterial protein toxins highjack host signalling pathways to create a suitable niche for the pathogen to colonize and persist. Helicobacter pylori VacA is paradigm of pore-forming toxins which contributes to the pathogenesis of peptic ulceration. Several cellular receptors have been described for VacA, which exert different effects on epithelial and immune cells. The crystal structure of VacA p55 subunit might be important for elucidating details of receptor interaction and pore formation. Here we discuss the multiple signalling activities of this important toxin and the molecular crosstalk between VacA and other virulence factors.

Indexed as

Helicobacter pyloriVacuolesAntigens, BacterialBacterial ProteinsCytotoxinsSignal TransductionVirulence FactorsAntigens, BacterialBacterial ProteinsCytotoxinsVirulence FactorsCagAHelicobacter pylorilipid raftspathogenicity islandsignallingtype IV secretionVacAvacuolating cytotoxin

Identifiers

PMID22069547
PMCPMC3206623
OpenAlexW2150574333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.